About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Denver | 7,466 Studies Near You

Clinical TrialsDenver

Clinical Trials in Denver

Discover 7,466 clinical trials near Denver, Colorado. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2541-2560 of 7,466 trials

CompletedSafety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the ToenailThis is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.NCT01400594·Birmingham, Alabama and 36 others

Find Trials by Condition in Denver

Breast Cancerin Denver Lung Cancerin Denver Prostate Cancerin Denver Colorectal Cancerin Denver Melanomain Denver Leukemiain Denver Lymphomain Denver Pancreatic Cancerin Denver Ovarian Cancerin Denver Brain Cancerin Denver Diabetesin Denver

Data from ClinicalTrials.govTerms

UnknownExcellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)This is a Phase 4, randomized clinical trial to evaluate whether addition of Vorapaxar 2.08 mg daily vs. placebo daily on background antiplatelet therapy, prescribed for 6 months…NCT02660866·Tucson, Arizona and 11 others

CompletedStep-up Yellow Zone Inhaled Corticosteroids to Prevent ExacerbationsThe objective of this study is to determine whether, in children receiving low-dose inhaled corticosteroids (ICS), quintupling the dose of inhaled corticosteroids at the onset of…NCT02066129·Tucson, Arizona and 17 others

CompletedRegistry of Amyloid Positive Patients for Alzheimer's Disease Drug Research TrialsThis registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in…NCT02918539·Glendale, Arizona and 74 others

TerminatedBortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell TransplantThis phase II trial is studying how well giving bortezomib together with liposomal doxorubicin hydrochloride, dexamethasone, and cyclophosphamide works in treating patients with…NCT01078441·Scottsdale, Arizona and 129 others

RecruitingAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseThis is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study, comprised of 3 sub-studies, to evaluate the efficacy and safety of…NCT07184931·Peoria, Arizona and 431 others

Active not recruitingFasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray…NCT06615557·Phoenix, Arizona and 25 others

CompletedGR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In AdultsThe primary objective is to estimate the size of the GR270773 treatment effect on 28-day all-cause mortality for two doses of GR270773 versus placebo in adult subjects with…NCT00089986·Birmingham, Alabama and 389 others

RecruitingA Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)Phase 1a/1b dose escalation and expansion study designed to evaluate the safety and tolerability of NVL-330, determine the recommended Phase 2 dose (RP2D), and evaluate the…NCT06521554·Irvine, California and 20 others

CompletedCollecting and Storing Samples of Blood and Tumor Tissue From Patients With OsteosarcomaThe purpose of this study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma.NCT00899275·Birmingham, Alabama and 179 others

RecruitingMaternal Newborn Health RegistryThe primary purpose of this population-based study is to quantify and understand the trends in pregnancy outcomes in defined low-resource geographic areas over time, in order to…NCT01073475·Birmingham, Alabama and 14 others

CompletedA Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 DiabetesThe purpose of this study is to evaluate the efficacy and safety of adding Symlin to an established regimen of insulin glargine in subjects with type 2 diabetes who are not…NCT00240253·Phoenix, Arizona and 33 others

TerminatedA Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of intravenous administration of XmAb662 monotherapy or in combination with pembrolizumab…NCT05996445·Denver, Colorado and 2 others

Active not recruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel and gemcitabine hydrochloride when given together with or without bevacizumab after surgery to see how well it…NCT00565851·Anchorage, Alaska and 708 others

Active not recruitingIntra-operative Pancreatoscopy in Patients With IPMNTo demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm…NCT03729453·Denver, Colorado and 7 others

Approved for marketingAn Expanded Access Program of Emicizumab in Participants With Hemophilia A With InhibitorsThis open-label, multicenter expanded access program (EAP) is designed to provide emicizumab to eligible participants with hemophilia A with factor VIII (FVIII) inhibitors before…NCT03154437·Aurora, Colorado and 13 others

CompletedA "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)Primary Objective: Demonstrate clinical benefit of Toujeo in achieving individualized Healthcare Effectiveness Data and Information Set (HEDIS) glycated hemoglobin (HbA1c)…NCT02451137·Birmingham, Alabama and 426 others

CompletedStudy of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid TumorsThe purpose of this clinical research study is to establish the maximum tolerated dose and recommended Phase II dose of Erbitux™ in combination with Irinotecan in pediatric and…NCT00110357·Phoenix, Arizona and 8 others

RecruitingStudy of CP-383 in Patients With Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383.NCT07030257·Denver, Colorado and 12 others

TerminatedA Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple SclerosisThe main purpose of this study is to investigate Lu AG06466 as a treatment for spasticity in participants with multiple sclerosis (MS).NCT04990219·Denver, Colorado and 6 others

PreviousPage 128 of 374Next

Heart Diseasein Denver